Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial

BACKGROUND: This study evaluated the effects of aclidinium bromide, a long-acting muscarinic antagonist indicated for maintenance treatment of chronic obstructive pulmonary disease (COPD), on exercise endurance, dyspnea, lung hyperinflation, and physical activity. METHODS: In this randomized, double...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Pulm Med
Hlavní autoři: Beeh, Kai M, Watz, Henrik, Puente-Maestu, Luis, de Teresa, Luis, Jarreta, Diana, Caracta, Cynthia, Gil, Esther Garcia, Magnussen, Helgo
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4364572/
https://ncbi.nlm.nih.gov/pubmed/25539654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-14-209
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky